Dergiler / Organic Communications / 2020 / Cilt: 13 - Sayı: 3

Synthesis of new fatty acid derivatives of oleanane and ursane triterpenoids and investigation of their in vitrocytotoxic effects on 3T3 fibroblast and PC3 prostate cancer cell lines

Sayfa
114–126
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Compounds5cand 8cdemonstrated the least toxic effect on 3T3 fibroblast human healthy cells and the highest toxic effect on PC3 prostate cancer cellsat a concentration of 12.5 μM.Moreover, compounds 8cand 8ehad the least toxic effect on 3T3 fibroblast human healthy cells and the highest toxic effect on PC3 prostate cancer cells at the same concentration.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:In this study, 12 new oleanane and ursane derivative triterpene compounds,havingfatty acids in the form of esters with carbon numbers of 12, 13, 18, 19, 24 and 25,were synthesized starting from naturalproductsoleanolic and ursolic acids.
📊
Temel Bulgular & Veri:Initially,3-methylerythrodiol (3β-methoxyolean-12-en-28-ol) and 3-methyluvaol(3β-methoxyurs-12-en-28-ol) were synthesized from oleanolic acid and ursolic acid,respectively.
💡
Sonuç & Katkı:Compounds5cand 8cdemonstrated the least toxic effect on 3T3 fibroblast human healthy cells and the highest toxic effect on PC3 prostate cancer cellsat a concentration of 12.5 μM.Moreover, compounds 8cand 8ehad the least toxic effect on 3T3 fibroblast human healthy cells and the highest toxic effect on PC3 prostate cancer cells at the same concentration.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

In this study, 12 new oleanane and ursane derivative triterpene compounds,havingfatty acids in the form of esters with carbon numbers of 12, 13, 18, 19, 24 and 25,were synthesized starting from naturalproductsoleanolic and ursolic acids. Initially,3-methylerythrodiol (3β-methoxyolean-12-en-28-ol) and 3-methyluvaol(3β-methoxyurs-12-en-28-ol) were synthesized from oleanolic acid and ursolic acid,respectively. For this purpose,secondary OH group at C-3 of oleanolic and ursolic acidswereprotected as methyl ether and,then,theircarboxylic acidmoietieswere reduced by aluminum hydride. New fatty acid derivatives5a-fand 8a-fwere synthesized through thereaction of 3-methylerythrodiol/3-methyluvaol and corresponding fatty acid halides. In vitrocytotoxic activitiesof the all synthesized compoundswere investigated on 3T3 fibroblast cells and PC3 prostate cancer cell lines. While all the compounds showedat least 70% inhibition on PC3 prostate cancer cells at a concentration of 25 μM, theyhadaverage of 50% inhibition on 3T3 fibroblast human healthy cells at the same concentration. Compounds5cand 8cdemonstrated the least toxic effect on 3T3 fibroblast human healthy cells and the highest toxic effect on PC3 prostate cancer cellsat a concentration of 12.5 μM.Moreover, compounds 8cand 8ehad the least toxic effect on 3T3 fibroblast human healthy cells and the highest toxic effect on PC3 prostate cancer cells at the same concentration.

🔖

Bu Makaleye Atıf Yap

ŞENOL, H., DAĞ, A., ÇOKULUDAĞ, K., AKTAŞ, A. S., ATASOY, S., TOPÇU, G. (2020). Synthesis of new fatty acid derivatives of oleanane and ursane triterpenoids and investigation of their in vitrocytotoxic effects on 3T3 fibroblast and PC3 prostate cancer cell lines. Organic Communications, Cilt: 13 - Sayı: 3, 114–126. https://ajindex.com/articles/288451

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (1)

  1. Anonymous, Acs releases 2005 edition of cancer facts & figures. Am. Fam. Physician2005,71(8),1612-1612. [2]Hausman, D. M., What is cancer? Perspect. Biol. Med. 2019,62(4),778-784. [3]Nygren, P.; Grp, S. B. U., What is cancer chemotherapy? Acta Oncol. 2001,40(2-3),166-174. [4]Schram, F. R.; Ng, P. K. L., What is cancer? J. Crust. Biol. 2012,32(4),665-672. [5]Popat, K.; McQueen, K.; Feeley, T. W., The global burden of cancer. Best Pract.Res.Clin.Anaesthesiol. 2013,27(4),399-408. [6]Parkin, D. M.; Bray, F.; Ferlay, J.; Pisani, P., Global cancer statistics, 2002. CA Cancer J. Clin. 2005,55(2),74-108. [7]Jemal, A.; Bray, F.; Center, M. M.; Ferlay, J.; Ward, E.; Forman, D., Global cancer statistics. CA Cancer J. Clin. 2011,61(2),69-90. [8]Chuang, K. Y.; Chuang, Y. C.; Ho, Y. S., Global influence of cancer statistics articles. Curr. Sci. 2015,109(9),1552-1554. [9]Bray, F.; Ferlay, J.; Soerjomataram, I.; Siegel, R. L.; Torre, L. A.; Jemal, A., Global cancer statistics 2018: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018,68(6),394-424. [10]Zorlu, F.; Divrik, R. T.; Eser, S.; Yorukoglu, K., Prostate cancer incidence in Turkey: An epidemiological study. Asian Pac. J. Cancer Prev. 2014,15(21), 9125-9130. [11]Attard, G.; Parker, C.; Eeles, R. A.; Schroder, F.; Tomlins, S. A.; Tannock, I.; Drake, C. G.; de Bono, J. S., Prostate cancer. Lancet 2016,387(10013),70-82. [12]Ilic, D.; Dahm, P., Prostate cancer screening in europe. Lancet 2015,385(9977), 1506-1506. [13]Dzubak, P.; Hajduch, M.; Vydra, D.; Hustova, A.; Kvasnica, M.; Biedermann, D.; Markova, L.; Urban, M.; Sarek, J., Pharmacological activities of naturaltriterpenoids and their therapeutic implications. Nat. Prod. Rep. 2006,23(3),394-411. [14]Zhang, Q.; Chang, Z.; Wang, Q., Ursane triterpenoids inhibit atherosclerosis and xanthoma in ldl receptor knockout mice. Cardiovasc.Drugs Ther. 2006,20(5),349-357. [15]Ukiya, M.; Akihisa, T.; Tokuda, H.; Suzuki, H.; Mukainaka, T.; Ichiishi, E.; Yasukawa, K.; Kasahara, Y.; Nishino, H., Constituents of compositae plants III. Anti-tumor promoting effects and cytotoxic activity against human cancer cell lines of triterpene diols and triols from edible chrysanthemum flowers. Cancer Lett. 2002,177(1),7-12. [16]Topcu, G., Bioactive triterpenoids from salvia species. J. Nat. Prod. 2006,69(3),482-487. [17]Liby, K. T.; Yore, M. M.; Sporn, M. B., Triterpenoids and rexinoids as multifunctional agents for the prevention